[Effect of rapamycin on NF-kappaB induction].
Kakegawa
Tomohito
T
Nemoto
Asayo
A
Matsuda
Megumi
M
Saito
Hiromi
H
Kobayashi
Hiroshi
H
D017398:Alternative Splicing / Q000187:drug effects; D001402:B-Lymphocytes / Q000378:metabolism; D002478:Cells, Cultured; D006801:Humans; D020672:I-kappa B Proteins / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008081:Liposomes / Q000378:metabolism; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D012261:Ribonucleoproteins / Q000378:metabolism; D020123:Sirolimus / Q000494:pharmacology*; D016559:Tacrolimus / Q000494:pharmacology
D020672:I-kappa B Proteins; D007166:Immunosuppressive Agents; D008081:Liposomes; D016328:NF-kappa B; C000606204:NFKBIA protein, human; D012333:RNA, Messenger; D012261:Ribonucleoproteins; C026452:messenger ribonucleoprotein; D000072000:NF-KappaB Inhibitor alpha; D020123:Sirolimus; D016559:Tacrolimus